Remove ACE Inhibitor Remove Heart Dysfunction Remove Myocardial Infarction
article thumbnail

SGLT-2 Inhibitors Show Mixed Results After Heart Attack

DAIC

The EMPACT-MI trial was designed to determine whether SGLT-2 inhibitors could safely help to prevent heart failure and reduce mortality in people with a high risk of heart failure following a heart attack. The study enrolled 6,522 people treated for acute myocardial infarction at 451 centers in 22 countries.

article thumbnail

EMPACT-MI Trial Outcomes Reported at ACC24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack

DAIC

The EMPACT-MI trial was designed to determine whether SGLT-2 inhibitors could safely help to prevent heart failure and reduce mortality in people with a high risk of heart failure following a heart attack. The study enrolled 6,522 people treated for acute myocardial infarction at 451 centers in 22 countries.